The present invention relates to a binder composition for a non-aqueous electrolyte battery, which is characterized by containing (A) polyvinyl alcohol, (B) at least one selected from a copolymer of vinyl alcohol and ethylenically unsaturated carboxylic acid and a neutralized salt of the copolymer and (C) at least one selected from an amino acid, a carboxylic acid-containing polymer and a polyamine; and a binder aqueous solution for a non-aqueous electrolyte battery, a slurry composition for a non-aqueous electrolyte battery, an electrode for a non-aqueous electrolyte battery, and a non-aqueous electrolyte battery, each containing the binder composition; and others.

The present invention relates to a binder composition for a non-aqueous electrolyte battery, which is characterized by containing (A) polyvinyl alcohol, (B) at least one selected from a copolymer of vinyl alcohol and ethylenically unsaturated carboxylic acid and a neutralized salt of the copolymer and (C) at least one selected from an amino acid, a carboxylic acid-containing polymer and a polyamine; and a binder aqueous solution for a non-aqueous electrolyte battery, a slurry composition for a non-aqueous electrolyte battery, an electrode for a non-aqueous electrolyte battery, and a non-aqueous electrolyte battery, each containing the binder composition; and others.

Provided is a graft copolymer and a treatment method which give excellent antifouling property to a substrate, especially a carpet. The graft copolymer has a trunk polymer having a hydroxyl group; and a branch having a C.sub.7-40 hydrocarbon group bonded to the trunk polymer at a carbon atom substituted with the hydroxyl group, wherein the branch has a repeating unit formed from an acrylic monomer represented by the formula: CH.sub.2═C(—X)—C(═O)—Y.sup.1—Z(—Y.sup.2—R).sub.n. The treatment method include applying the graft copolymer to the substrate.

Provided is a graft copolymer and a treatment method which give excellent antifouling property to a substrate, especially a carpet. The graft copolymer has a trunk polymer having a hydroxyl group; and a branch having a C.sub.7-40 hydrocarbon group bonded to the trunk polymer at a carbon atom substituted with the hydroxyl group, wherein the branch has a repeating unit formed from an acrylic monomer represented by the formula: CH.sub.2═C(—X)—C(═O)—Y.sup.1—Z(—Y.sup.2—R).sub.n. The treatment method include applying the graft copolymer to the substrate.

A grafted polyvinyl alcohol polymer includes a polyvinyl alcohol main chain and a plurality of side chains grafted to the polyvinyl alcohol main chain. One or more of the side chains from the plurality of side chains include one or more units selected from: an aliphatic carboxylic acid, an aliphatic amide, an amino alkyl (meth)acrylate, a hydroxylated alkyl (meth)acrylate, or any combinations thereof. The grafted polyvinyl alcohol polymer can be included in a formulation that also includes water, and the formulation can be used as an adhesive in a creping process.

A grafted polyvinyl alcohol polymer includes a polyvinyl alcohol main chain and a plurality of side chains grafted to the polyvinyl alcohol main chain. One or more of the side chains from the plurality of side chains include one or more units selected from: an aliphatic carboxylic acid, an aliphatic amide, an amino alkyl (meth)acrylate, a hydroxylated alkyl (meth)acrylate, or any combinations thereof. The grafted polyvinyl alcohol polymer can be included in a formulation that also includes water, and the formulation can be used as an adhesive in a creping process.

A grafted polyvinyl alcohol polymer includes a polyvinyl alcohol main chain and a plurality of side chains grafted to the polyvinyl alcohol main chain. One or more of the side chains from the plurality of side chains include one or more units selected from: an aliphatic carboxylic acid, an aliphatic amide, an amino alkyl (meth)acrylate, a hydroxylated alkyl (meth)acrylate, or any combinations thereof. The grafted polyvinyl alcohol polymer can be included in a formulation that also includes water, and the formulation can be used as an adhesive in a creping process.

A hydrophilic polymer comprising pendent groups of the formula I: Wherein: W is independently selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1—(C═O)—O—C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; or a group —BZ; wherein —OH, COOH, O—PO.sub.3H and SO.sub.3H maybe in the form of a pharmaceutically acceptable salt; wherein: B is a bond, or a straight branched alkanediyl, oxyalkylene, alkylene oxaalkylene, or alkylene (oligooxalkylene) group, optionally containing one or more fluorine substituents; and Z is an ammonium, phosphonium, or sulphonium phosphate or phosphonate ester zwitterionic group; X is either a bond or a linking group having 1 to 8 carbons and optionally 1 to 4 heteroatoms selected from O, N and S; G is a coupling group through which the group of the formula I is coupled to the polymer and is selected from ether, ester, amide, carbonate, carbamate, 1,3 dioxolone, and 1,3 dioxane; R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2 q is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 3; and n+p is from 2 to 5; and wherein —COOH, —OPO.sub.3H.sub.2 and —SO.sub.3H as well as phenolic —OH maybe in the form of a pharmaceutically acceptable salt.

A hydrophilic polymer comprising pendent groups of the formula I: Wherein: W is independently selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1—(C═O)—O—C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; or a group —BZ; wherein —OH, COOH, O—PO.sub.3H and SO.sub.3H maybe in the form of a pharmaceutically acceptable salt; wherein: B is a bond, or a straight branched alkanediyl, oxyalkylene, alkylene oxaalkylene, or alkylene (oligooxalkylene) group, optionally containing one or more fluorine substituents; and Z is an ammonium, phosphonium, or sulphonium phosphate or phosphonate ester zwitterionic group; X is either a bond or a linking group having 1 to 8 carbons and optionally 1 to 4 heteroatoms selected from O, N and S; G is a coupling group through which the group of the formula I is coupled to the polymer and is selected from ether, ester, amide, carbonate, carbamate, 1,3 dioxolone, and 1,3 dioxane; R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2 q is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 3; and n+p is from 2 to 5; and wherein —COOH, —OPO.sub.3H.sub.2 and —SO.sub.3H as well as phenolic —OH maybe in the form of a pharmaceutically acceptable salt.

A preparation method of a hydrogel of a mercapto-modified macromolecular compound includes the steps of combining the mercapto-modified macromolecular compound with an acrylated macromolecular compound and/or an acrylated micromolecular crosslinker. The mercapto-modified macromolecular compound can be crosslinked with the acrylated macromolecular compound and/or the acrylated micromolecular crosslinker under physiological conditions to form the hydrogel. Due to the rapid mercapto-vinyl crosslinking reaction, the formed hydrogel system can be quickly gelled in situ after being injected into the body. The hydrogel is thus suitable for use in the fields of biomedicine, medical cosmetic plastic surgery and cosmetics.